Is Cameco Worth Buying as Premium Valuation Meets Execution Risk?

Impact · against what's priced in

The article provides no new catalysts for CEG or LEU and primarily reinforces the existing valuation risks for CCJ. While the nuclear demand thesis remains intact, the emphasis on CCJ's premium valuation confirms that the market is already pricing in significant execution success, leaving the stock vulnerable to any operational misses.

CCJ+0.00

Already priced in

The price assumes

the structural uranium supply deficit covering 74-90% of annual demand